Skip to main content

Find Clinical Trials

Home
Conditions
Recurrence

Clinical trial condition

Recurrence

Explore clinical trials studying Recurrence. Study availability and eligibility vary by location and protocol.

2,312 public trials 521 recruiting studies

Refine in advanced search Browse all conditions

Recurrence trial results

Completed

Panobinostat or Placebo With Bortezomib and Dexamethasone in Patients With Relapsed Multiple Myeloma

NCT01023308

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
Locations: Novartis Investigative Site Phoenix, Arizona, United States

Novartis Investigative Site Anaheim, California, United States

Novartis Investigative Site Concord, California, United States

Novartis Investigative Site Los Angeles, California, United States

View all 210 locations

View Trial Details

Completed

Follow Up of High Risk Hodgkin Lymphoma in First Complete Remission

NCT04298619

Conditions: Disease Attributes, Hemic and Lymphatic Diseases, High Risk, +13 more
Locations: Not specified

View Trial Details

Completed

A PhaseⅠb Study Evaluating Safety and Efficacy of C-CAR011 Treatment in B- NHL Subjects

NCT03483688

Conditions: B-Cell Non-Hodgkin Lymphoma, Disease Attributes, Hemic and Lymphatic Diseases, +12 more
Locations: Peking Union Medical College Hospital Beijing, Beijing Municipality, China

View Trial Details

Completed

A Study of Ibrutinib in Combination With Bendamustine and Rituximab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

NCT01611090

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +16 more
Locations: Birmingham, Alabama, United States

Phoenix, Arizona, United States

Berkeley, California, United States

Duarte, California, United States

View all 155 locations

View Trial Details

Completed

Phase 1/2 Safety and Efficacy of PLX3397 in Adults With Relapsed or Refractory Acute Myeloid Leukemia (AML)

NCT01349049

Conditions: Acute Myeloid Leukemia, Disease Attributes, Hematologic Diseases, +9 more
Locations: UCSF Helen Diller Family Family Comprehensive Cancer Center San Francisco, California, United States

Northwestern University Chicago, Illinois, United States

Johns Hopkins University Baltimore, Maryland, United States

Dana Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Completed

Lenalidomide, MTX, Ara-C and Rituximab in Relapsed Aggressive B-cell Lymphomas

NCT01788189

Conditions: B-cell Lymphoma, Disease Attributes, Hemic and Lymphatic Diseases, +12 more
Locations: Klinik für Hämatologie, Universitätsklinikum Essen Essen, Germany

View Trial Details

Completed

ANG1005 in Patients With Recurrent High-Grade Glioma

NCT01967810

Conditions: Astrocytoma, Brain Diseases, Brain Neoplasms, +19 more
Locations: Moores UC San Diego Cancer Center La Jolla, California, United States

Northwestern University Chicago, Illinois, United States

Massachusetts General Hospital Boston, Massachusetts, United States

Beth Israel Deaconess Medical Center Boston, Massachusetts, United States

View Trial Details

Completed

MRD-directed Donor Lymphocyte Infusion for Reduce of Relapse After Allo-HSCT

NCT02673008

Conditions: Disease Attributes, Donor Lymphocyte Infusion, Hematopoietic Stem Cell Transplantation, +8 more
Locations: Department of Hematology,Nanfang Hospital, Southern Medical University Guangzhou, Guangdong, China

View Trial Details

Completed

Clofarabine, Idarubicin, and Cytarabine (CIA) Versus Fludarabine, Idarubicin, and Cytarabine (FLAI) in Acute Myelogenous Leukemia (AML) and High-Risk Myelodysplastic Syndrome

NCT01289457

Conditions: Disease Attributes, Hematologic Diseases, Hemic and Lymphatic Diseases, +8 more
Locations: University of Texas MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Bortezomib With Chemotherapy for Relapsed Pediatric Acute Lymphoblastic Leukemia (ALL)

NCT00440726

Conditions: Acute Lymphoblastic Leukemia, Disease Attributes, Hematologic Diseases, +13 more
Locations: City of Hope Duarte, California, United States

Miller Children's Hospital Long Beach, California, United States

Childrens Hospital Los Angeles Los Angeles, California, United States

Children's Hospital & Research Center Oakland Oakland, California, United States

View all 24 locations

View Trial Details